PAA

2.63%

19.5¢ pharmaust limited

KPax you can have a months worth of GA'S from me as its my...

First 2 Last

Share
Profile

Follow
stagbill58

329 Posts.

55

10/09/20

15:12

Post #: 47243141
Share

Originally posted by kpax: ↑

There is a fast track approval to make Monepantel and its metabolite Sulfone available to make the medicine available to patients sooner than normal.

It is under the Priority Review Pathway Therapeutics Goods Administration Australia.
They can give provisional approval to medicines which provide a promising treatment for a serious or life threatening condition. Therefore the medicine MPL can be available for limited period whilst the Pharmaceutical Company completes its trials.

There is also funding available through the Australian Government via the “ Medical Research Future Fund “ up to $66 million .

As some of you know I am only interested per se in the Science. But I am seriously concerned about the speed of delivery to mankind of potential cures .

The economy world wide has been seriously affected by this virus. Either we have a cure or we don’t.
A Company in a position of having a cure must fast track all efforts.

For the last 113 days since we were informed that PAA is testing MPL/S against the virus I conclude ( by analysing relevant announcements) that there has been a maximum of 11 tests with a minimum of 6 . The announcements are ambiguous in this regard. So that’s at best one assay study every 10 days or at worse one study every 18 days. As per PAA announcements every study takes 72 hours to complete.

PAA has even studied Rapamycin on the virus. You will find not one study in the world that tested Rapamycin in this mode. Why ? Rapamycin is a treatment adjunct ( it is used with other drugs ) . It has anti inflammatory properties. It is used for people having an immunological cytokine reaction to Covid-19. Aspirin also has those properties as well. Has anyone tested aspirin v the virus. No . Because it won’t work. Rapamycin is not an anti viral . Research this and see the futility and waste of money, but the time factor is paramount.

So , what is going on people ? Yes, a Company that is trialling a drug can take their time in the normal sense. But, we are talking continual economic devastation of the Worlds economy.
The cost to us all is frightening. Have we the ability to fast track a drug that may work. Yes.
Do you as shareholders want a quick answer ? Do we as mankind want a quick answer ?

I and my peers are exasperated at this juncture. Everything is at a snails pace.
Our Directors in this Company who are fragmentated all over the world need a rocket.
Do they realise the significance of what we have . YES. Do they have the acumen to tackle this danger with all the resources disposable to them. I fear the answer.

We have full patent protection in Australia due to special legislation passed in March 2020. Amended Chapter 12. It is known as PPI cumpolsury acquisition of a patent if it is in the interests of Australia.

We don’t need to ask Eli Lilly if we can test our drug due to Eli Lilly testing three of theirs on Covid 19.
Remembering that Elanco is owned 80% by Eli Lilly.

This situation needs immediate action.

If not, I can categorically guarantee 100% that a cure will be found using MPL but not in Australia.
I do not jest !

Expand

KPax you can have a months worth of GA'S from me as its my nightmare that pirate drug nations such as China ,Russia ,India and even Usa will simply bypass our patents and start production asap

PAA Price at posting: 14.0¢ Sentiment: Hold Disclosure: Held
7 Upvote

0 Great analysis

Reply

Top Stories

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

BUX

Buxton projects new graphite province discovery at WA Narryer play

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

There are more pages in this discussion • 117 more messages in this thread...

First 2 Last

Add PAA (ASX) to my watchlist

(20min delay)
Last 19.5¢		Change 0.005(2.63%)		Mkt cap ! $94.89M

Open	High	Low	Value	Volume
19.0¢	19.5¢	19.0¢	$58.40K	305.6K

Buyers (Bids)

No.	Vol.	Price($)
2	115000	19.0¢

Sellers (Offers)

Price($)	Vol.	No.
19.5¢	86074	3

View Market Depth

No.	Vol.	Price($)
1	100000	0.190
8	156232	0.185
10	635662	0.180
10	482365	0.175
8	151233	0.170

Price($)	Vol.	No.
0.195	86074	3
0.200	256824	3
0.205	113150	5
0.210	333355	8
0.215	266995	7

Last trade - 16.10pm 04/10/2024 (20 minute delay)

PAA (ASX) Chart

KPax you can have a months worth of GA'S from me as its my...

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Buxton projects new graphite province discovery at WA Narryer play

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

BCI reaches close of funding facility for salt-first part of Mardie project

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

KPax you can have a months worth of GA'S from me as its my...

Top Stories

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Buxton projects new graphite province discovery at WA Narryer play

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

BCI reaches close of funding facility for salt-first part of Mardie project

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News